GlassScriptPhysician profile
Soo K Abboud
NPI 1821033440
$22,893.85
in general payments reported to CMS, 2019-2025
6 companies · $6,012 in 2025
The $6,012 reported for 2025 was more than what 96% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $74.26 · 2020: $75.20 · 2021: $2,233 · 2022: $5,361 · 2023: $7,600 · 2024: $1,538 · 2025: $6,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $11K · Honoraria: $4,000 · Food and Beverage: $525.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $10,625.00 |
| Honoraria | $4,000.00 |
| Food and Beverage | $524.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $18,749.06 | 2019-2025 | |
| Horizon Therapeutics Plc | $4,000.00 | 2023 | Tepezza |
| Glaxosmithkline, LLC. | $53.60 | 2022-2024 | Nucala |
| Medtronic, INC. | $44.40 | 2025 | Rapidvac, V-Loc 180 |
| Pharming Healthcare, INC. | $26.00 | 2022 | |
| Boston Scientific Corporation | $20.79 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Soo Abboud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.